Documente Academic
Documente Profesional
Documente Cultură
FLUOROCHINOLONE
II
III
Reprezentant
ACID NALIDIXIC
NORFLOXACINA
CIPROFLOXACINA
LOMEFLOXACINA
OFLOXACINA
LEVOFLOXACINA
SPARFLOXACINA
Spectru antimicrobian
- Bacili G(-) (NU i Pseudomonas species)
IV
CLINAFLOXACINA*
GATIFLOXACINA*
MOXIFLOXACINA*
TROVAFLOXACINA
ALATROFLOXACINA
Generaia a II-a +
Germeni penicilino-rezisteni
Germeni patogeni atipici (micoplasme, chlamidii,
ureaplasme, legionella)
Mycobacterii (tuberculosis, M.avium intracelulare)
DERIVAT DE NAFTIRIDIN
DERIVAI DE CHINOLIN
O
F
COOH
H3C
NORFLOXACINA
HN
COOH
C2H5
C2H5
ACID NALIDIXIC
O
F
CIPROFLOXACINA
R5
R6
R7
HN
COOH
COOH
X
R8
R1
O
CH3
LOMEFLOXACINA
HN
COOH
N
F
STRUCTURA GENERAL
C2H5
O
F
OFLOXACINA
H3C N
COOH
N
O
CH3
F
H3C N
COOH
N
O
H2N
LEVOFLOXACINA
CH3
HN
CLINAFLOXACINA
O
O
F
COOH
COOH
N
CH3
N
Cl
CH3
NH2
COOH
HN
N
F
N
OCH3
CH3
GEN. A IV-A
GATIFLOXACINA
SPARFLOXACINA
O
F
H
N
COOH
N
OCH3
GEN. A III-A
MOXIFLOXACINA
O
F
N
COOH
N
H2N
F
F
TROVAFLOXACINA
OBINEREA CIPROFLOXACINEI
Cl
Cl
+ CH2(COOC2H5)2
F
1
TsOH
- CO2
-C2H5OH
Cl
Cl
F
CO
CO
CH - HN
C - COOC2H5
NaH Cl
F
N
F
COOH
7
CH - OC2H5
C - COOC2H5
N
COOH
6
NH
HN
CO
Cl
Cl
Cl
HC(OC2H5)3 Cl
CH2COOC2H5
CH(COOC2H5)2
CO
HN
(H5C2O)2Mg Cl
COCl
H2N
Cl
MECANISM DE ACIUNE
Legare de ADN
Legare de
enzim
Legare de
enzim
Autoasamblare
4 molecule
Aciune chelatant
CH2 - CH3
H3C
N
C
CH2 - CH3
H3C
N
C
O
O
complex 2:1
Me
Me
complex 1:1
O
C
H3C
N
CH2 - CH3
REZISTENA LA FLUOROCHINOLONE
POMP DE EFLUX
REDUCEREA
PERMEABILITII
MUTAII
CH3: G(+)
NH2: G(-)
R5
HN
G(-)
R7
COOH
X8
N
R1
G(+)
Anaerobi
F
N
H2N
Micobacterii
G(-)
G(+)
Anaerobi
Micobacterii
Anaerobi
C(CH3)3
F
OCH3
PROPRIETI FARMACOCINETICE - FQ
Absorbie i biodisponibilitate
-rapid i aproape complet (1 or), nemodificat semnificativ de
ctre alimente
-legare 10-40% de proteinele plasmatice
Distribuie - larg, practic n toate esuturile, Vd mari (exceptie
NORFLOXACINA concentratii serice scazute)
-esut prostatic i lichid seminal
-parenchim renal
-esut muscular, esut osos
-sfera ORL, glande salivare, secreie bronic
-tract genital
-T1/2 4-12 ore + efect post-antibiotic
-Metabolizare hepatic, inhibitori Cyt P450
-Eliminare - renal, biliar, hepatic ca atare sau metabolii
DCI
Specialiti
Forme farmaceutice
cp. 400 mg, sol.oftalmic, 2x400 mg/zi
NORFLOXACIN, NOLICIN- cp
CHIBROXIN sol.oft.
OFLOXACIN, ZANOCIN
Levofloxacina
LEVAQUIN (Frana)
Sparfloxacina
Gatifloxacina
Moxifloxacina
AVELOX
Trovafloxacina
Lomefloxacina
OKACIN, LOMADAY
Norfloxacin
Ciprofloxacina
Ofloxacina
CONTRAINDICAII
-gravide - anemie hemolitic, acidoz metabolic sever a nou-nscutului, afectare
a cartilagiilor
-copii cu vrsta mai mic de 18 ani (levofloxacina, fluorochinolone gen. a IV-a)
-Pacieni cu deficit de G-6PDH
-Pacieni cu epilepsie
PRECAUII
-insuficien hepatic i tratament asociat cu anticoagulante
-insuficien renal
-conductori auto
-evitarea expunerii la radiaii UV
-Pacieni cu aritmii cardiace
Legare de receptori
GABA
Penetrare SNC
R5
F
HN
R
COOH
R7
X8
Inhibarea CytP450
N
R1
C2H5
Fototoxicitate
N
F
H2N
Substituenti
putin voluminosi
Inhibarea CytP450
>
Cl
>>
OCH3
INTERACIUNI
NU SUNT BENEFICE SAU SE ADMINISTREAZ CU PRECAUIE
-Compui ce conin metale bivalente i/sau trivalente - SPAIERE 2-4 ore
-Medicamentele antiacide
-Medicamentele antianemice (sruri de fier)
-Produse lactate
-Ioni complexani n urin cristalurie
-Medicamente anticoagulante crete efectul anticoagulant
-Medicamente cu structur xantinic - (cafein, teofilin) - risc convulsiv
-Benzodiazepine (diazepam, alprazolam, etc) - risc convulsivant
-AINS (diclofenac, ibuprofen) efect redus risc convulsivant
-Antibiotice ce inhib sinteza proteic (cloramfenicol), tetracicline ef. antagonic
-Derivai de nitrofuran interaciune chimic + efect antagonic
ASOCIERI BENEFICE
-Antibiotice: beta-lactamine, aminoglicozide, polimixine, sulfamide ef. sinergic